FIELD: medicine.
SUBSTANCE: invention refers to a method of treating a malignant tumour in an individual providing administering (a) temozolomide or bevacizumab and (b) a heat shock protein (HSP) preparation. The preparation contains such HSPs, as hsp70, hsp90 and gp96 administered separately or in a combination.
EFFECT: invention is effective in treating malignant tumours.
20 cl, 1 dwg, 2 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF HEAT SHOCK PROTEINS FOR IMPROVEMENT OF THERAPEUTICAL EFFECT OF NON-VACCINAL MEDICINAL EFFECT | 2003 |
|
RU2376029C2 |
| METHOD OF OBTAINING COMPOSITIONS INCLUDING HEAT SHOCK PROTEINS OR ALPHA-2-MACROGLOBULIN, SUITABLE FOR TREATMENT OF MALIGNANT TUMOUR AND INFECTIOUS DISEASE | 2002 |
|
RU2335295C2 |
| APPLICATION OF HEAT-SHOCK PROTEINS FOR IMPROVING EFFECTIVENESS OF ANTIBODY THERAPIES | 2003 |
|
RU2375077C2 |
| USE OF LECTINS FOR GLYCOPROTEIDS AND ANTIGENIC MOLECULES OLIGOMERISATION ACTIVATION | 2004 |
|
RU2399381C2 |
| VACCINE COMPOSITIONS, METHODS FOR APPLICATION THEREOF IN MELANOMA PREVENTION AND TREATMENT, AND GENETIC CONSTRUCTIONS FOR OBTAINING ACTIVE SUBSTANCES OF COMPOSITION | 2006 |
|
RU2333767C2 |
| VACCINE COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF TUMOR DISEASES, RECOMBINANT PLASMID DNA PROVIDING HYBRID PROTEIN SYNTHESIS AND METHOD FOR PRODUCTION THEREOF | 2006 |
|
RU2316342C1 |
| METHOD OF THERAPY OF MALIGNANT DISEASES | 2013 |
|
RU2597414C2 |
| PROTEIN-PEPTIDE ANTITUMOR COMPOSITION, CELL PREPARATION ACTIVATED THEREWITH AND METHOD FOR TUMOR PROPHYLAXIS OR TREATMENT | 2004 |
|
RU2283129C1 |
| METHOD FOR TREATING INFECTION CAUSED WITH HUMAN PAPILLOMA VIRUS (HPV) | 2001 |
|
RU2282461C2 |
| METHOD OF TREATING ONCOLOGICAL DISEASES | 2008 |
|
RU2379055C1 |
